🔎 Trials Near Me

Akèy › Hypertension artérielle › Kalifòni

Etid klinik pou Hypertension artérielle nan Kalifòni

28 etid pou Hypertension artérielle ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, San Jose
  • Retension Clinical Site, West Hills
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07142356

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • Adventist Health Glendale, Glendale
  • Sutter Valley Hospitals, San Francisco
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06059638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Thrive Clinical Research Group, Glendora
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • National Heart Institute, Beverly Hills
  • Hope Clinical Research, Canoga Park
  • John Muir Physician Network Clinical Research Center, Concord
  • ak 11 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Orange County Research Center, Lake Forest
  • Healthy Brain Clinic, Long Beach
  • Los Angeles Institute for Metabolic Research, Los Angeles
  • ak 6 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Beverly Hills
  • Research Site, Concord
  • Research Site, Fremont
  • ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • Cedar-Sinai Medical Center, Los Angeles
  • Stanford University, Palo Alto
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Beverly Hills
  • Clinical Trial Site, Chula Vista
  • Clinical Trial Site, Covina
  • ak 20 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

  • Clinical Trial Site, Lake Forest
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07553442

REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension

  • Kaiser Permanente Northern California, Oakland
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07780500

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404

Secondhand Tobacco Smoke and Cardiovascular Disease

  • San Francisco Veterans' Affairs Medical Center, San Francisco
Ap rekriteFaz 4
Laj 40 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04715568

Global Paradise System US Post Approval Study

  • Tibor Rubin VA Medical Center, Long Beach
  • Cedars-Sinai Medical Center, Los Angeles
  • Sutter Institute for Medical Research, Sacramento
  • ak 2 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • University of California, Irvine
  • Antelope Valley Medical Center, Lancaster
  • Stanford Medical Center (Stanford Health Care), Palo Alto
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Aug 7, 2026 · NCT06402968

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Clinical Trials Research, Lincoln
  • Downtown L A Research Center Inc, Los Angeles
  • Valley Clinical Trials, Northridge
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • NICRs Research Center, Garden Grove
  • Downtown L A Research Center Inc, Los Angeles
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

  • University of California, San Diego, La Jolla
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07725250

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

  • Bayview Research Group, Valley Village
  • Focus Clinical Research, West Hills
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06843577

SPYRAL GEMINI Pilot Study

  • Stanford Hospital and Clinics, Stanford
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

  • Wellth Inc., Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT06876233

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Chula Vista
  • Vanda Investigative Site, Dublin
  • Vanda Investigative Site, Valencia
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07090161

Blood Pressure Care for Advancing Real-World Evidence (BPCARE)

  • Family Health Centers of San Diego, San Diego
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT07398391

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

  • Loma Linda University Health, Loma Linda
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Feb 4, 2026 · NCT05551104

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

  • UCSF, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Dec 16, 2025 · NCT06039176

Technology-enabled Management Versus Usual Care for Blood Pressure

  • Stanford Health Care, Palo Alto
Ap rekrite
Laj 30 a 90 · Tout sèks · Mizajou Aug 11, 2025 · NCT05479461

Acupuncture Therapy and Hypertension

  • Susan Samueli Integrative Health Institute, Irvine
  • University of California, Irvine, Health Sciences Medical Center, Orange
Ap rekrite
Laj 45 a 75 · Tout sèks · Mizajou Jul 20, 2025 · NCT05530512

Effect of Electro-Acupuncture on Blood Pressure

  • Susan Samueli Integrative Health Institute, Irvine
  • UCIMedical Center, Orange
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Apr 15, 2025 · NCT00932139

Multi-Omics for Maternal Health After Preeclampsia

  • University of California, San Diego, San Diego
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 50 · Fanm · Mizajou Apr 6, 2025 · NCT06340152

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.